Lantheus Holdings (LNTH) EBIT Growth (5y) (2019 - 2026)
Lantheus Holdings (LNTH) EBIT Growth (5y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Lantheus Holdings | 6.72 Bn | 6.22 Bn | 230.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 39.09% |
| Dec 31, 2025 | 171.74% |
| Sep 30, 2025 | 59.45% |
| Jun 30, 2025 | 77.99% |
| Mar 31, 2025 | 70.30% |
| Dec 31, 2024 | 55.72% |
| Sep 30, 2024 | 73.46% |
| Jun 30, 2024 | 47.86% |
| Mar 31, 2024 | 45.83% |
| Dec 31, 2023 | 52.00% |
| Sep 30, 2023 | 46.80% |
| Jun 30, 2023 | 50.79% |
| Mar 31, 2023 | -21.22% |
| Dec 31, 2022 | -83.22% |
| Sep 30, 2022 | 46.23% |
| Jun 30, 2022 | 28.70% |
| Mar 31, 2022 | 37.64% |
| Dec 31, 2021 | -37.48% |
| Sep 30, 2021 | -25.70% |
| Jun 30, 2021 | -31.21% |